Viewing data from:

CICLOPIROX

ANDA

CICLOPIROX | A077364 | PADAGIS ISRAEL PHARMACEUTICALS LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: LOPROX(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 3 NDCs

Highest NADAC/Unit

$0.2171

per gm

Lowest NADAC/Unit

$0.1045

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
45802013835CICLOPIROX 0.77% CREAM	$0.2171	GM	Generic	—	2026-08-19
45802013811CICLOPIROX 0.77% CREAM	$0.1729	GM	Generic	—	2026-08-19
45802013818CICLOPIROX 0.77% CREAM	$0.1045	GM	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$16.31

Highest Price

$22.59

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
63629-8625-01CICLOPIROX OLAMINE 0.77% CREAM,TOP	$22.59	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
72162-1397-03CICLOPIROX OLAMINE 0.77% CREAM,TOP	$16.31	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain7 active DMFs4 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

OLON SPACICLOPIROX OLAMINE

DMF 113891995

ERREGIERRE SPACICLOPIROX OLAMINE USP-PH.EUR.

DMF 163522003

ERREGIERRE SPACICLOPIROX USP-EP

DMF 163532002

PCASCICLOPIROX

DMF 170072003

OLON SPACICLOPIROX

DMF 171562004

INTERQUIM SACICLOPIROX USP

DMF 189292005

KUMAR ORGANIC PRODUCTS LIMITEDCICLOPIROX OLAMINE

DMF 423042025

EUROAPI GERMANY GMBHInactiveCICLOPIROX

DMF 146271999

SANOFI AVENTIS DEUTSCHLAND GMBHInactiveCICLOPIROX OLAMINE

DMF 146331999

PIERRE FABRE MEDICAMENTInactiveCICLOPIROX

DMF 171992004

SYNKEM SASInactiveCICLOPIROX

DMF 173472004

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 0.77%

0 patents0 exclusivities▴

CREAM;TOPICAL | Approved: Mar 3, 2006

No patent or exclusivity listings for this strength.